Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force

ABSTRACT: Background: Cognitive impairments are an emerging treatment target in mood disorders, but currently there are no evidence-based pro-cognitive treatments indicated for patients in remission. With this systematic review of randomised controlled trials (RCTs), the International Society for Bi...

Full description

Autores:

López Jaramillo, Carlos Alberto
Miskowiak, Kamilla W.
Seeberg, Ida
Jensen, Mette B.
Balanzá Martínez, Vicent
Del Mar Bonnin, Caterina
Bowie, Christopher R.
Carvalho, Andre F
Dols, Annemieke
Douglas, Katie
Gallagher, Peter
Hasler, Gregor
Lafer, Beny
Lewandowski, Kathryn E.
Martínez Aran, Anabel
McIntyre, Roger S.
Porter, Richard J.
Purdon, Scot E.
Schaffer, Ayal
Stokes, Paul
Sumiyoshi, Tomiki
Torres, Ivan J.
Van Rheenen, Tamsyn E.
Yatham, Lakshmi N.
Young, Allan H.
Kessing, Lars V.
Burdick, Katherine E.
Vieta, Eduard

Tipo de recurso:

Review article

Fecha de publicación:

2022

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/42119

Acceso en línea:

https://hdl.handle.net/10495/42119

Palabra clave:

Bipolar Disorder
Transtorno Bipolar
Cognition
Cognición
Cognitive Dysfunction
Disfunción Cognitiva
Lurasidone Hydrochloride
Clorhidrato de Lurasidona
Mood Disorders
Trastornos del Humor
https://id.nlm.nih.gov/mesh/D001714
https://id.nlm.nih.gov/mesh/D003071
https://id.nlm.nih.gov/mesh/D060825
https://id.nlm.nih.gov/mesh/D000069056
https://id.nlm.nih.gov/mesh/D019964

Rights

openAccess

License

https://creativecommons.org/licenses/by/4.0/